All stocks ยท ISHITADR
ID

Ishita Drugs & Industries Ltd.

ISHITADR BSE Drug Manufacturers - Specialty & Generic Healthcare

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/โ€ฆ

ISIN INE806D01016
Listed โ€”
Quarters tracked 13
Filings 19 docs

About

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in Ahmedabad, India.

Key Metrics

as of Sep 2026
Market Cap22 Cr
P/E30.70
Div Yield0.00 %
Book Valueโ‚น38.70
52w Highโ‚น90.80
52w Lowโ‚น66.00
Face Valueโ‚น10.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 3.15 3.06 3.14 3.07 5.40 4.56 4.13 3.27 3.03 4.50 3.21 4.40 3.09
Expenses 2.84 2.96 3.00 2.89 5.06 4.27 3.83 3.03 2.86 4.20 2.99 4.18 2.91
Operating Profit 0.31 0.10 0.14 0.18 0.34 0.29 0.30 0.24 0.17 0.30 0.22 0.22 0.18
OPM % 9.84 3.27 4.46 5.86 6.30 6.36 7.26 7.34 5.61 6.67 6.85 5.00 5.83
Other Income 0.04 0.22 0.10 0.07 0.09 0.16 0.07 0.05 0.06 0.10 0.01 0.10 0.07
Depreciation 0.05 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.01 0.03 0.03 0.03
Interest 0.00 0.02 0.02 0.00 0.02 0.04 0.02 0.00 0.01 0.02 0.04 0.01 0.03
Profit before tax 0.30 0.28 0.19 0.22 0.38 0.38 0.32 0.26 0.19 0.37 0.16 0.28 0.19
Tax % 23.33 35.71 21.05 36.36 23.68 23.68 25.00 23.08 26.32 24.32 25.00 25.00 26.32
Net Profit 0.23 0.18 0.16 0.14 0.30 0.29 0.24 0.19 0.15 0.28 0.12 0.21 0.14
EPS in Rs 0.77 0.60 0.54 0.47 1.00 0.97 0.80 0.64 0.50 0.94 0.40 0.70 0.47

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 14.6615.0015.1912.0714.0913.9514.839.096.906.447.107.54
Expenses 13.8914.0114.2811.3113.0113.0314.078.576.456.086.827.23
Operating Profit 0.770.990.910.761.080.920.760.520.450.360.280.31
OPM % 5.256.605.996.307.676.595.125.726.525.593.944.11
Other Income 0.470.340.280.200.110.310.160.160.120.080.130.17
Interest 0.060.070.090.050.020.030.030.060.110.040.060.04
Depreciation 0.100.110.110.130.130.150.180.160.140.140.150.15
Profit before tax 1.081.150.990.781.041.050.710.460.320.260.200.29
Tax % 27.7825.2224.2425.6423.0820.9523.9426.0925.0030.7730.0024.14
Net Profit 0.780.870.750.580.800.830.550.350.250.180.140.22
EPS in Rs 2.612.912.511.942.682.781.841.170.840.600.470.74
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 2.992.992.992.992.992.992.992.992.992.992.992.99
Reserves 8.587.806.936.185.614.803.973.423.072.822.642.50
Borrowings 0.083.900.000.960.000.040.290.200.130.011.130.09
Other Liabilities 0.951.600.891.272.661.432.301.730.971.371.431.37
Total Liabilities 12.6016.2910.8111.4011.269.269.558.347.167.198.196.95
Fixed Assets 0.880.880.800.890.881.001.141.301.191.021.111.26
CWIP 1.750.000.000.000.000.000.000.000.000.000.000.00
Investments 4.453.873.343.394.063.115.294.043.152.702.151.82
Other Assets 5.5211.546.677.126.325.153.123.002.823.474.933.87
Total Assets 12.6016.2910.8111.4011.269.269.558.347.167.198.196.95

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 3.92-3.642.12-2.903.08-0.671.050.790.720.520.260.11
Cash from Investing Activity -2.24-0.670.130.59-0.932.45-1.15-1.06-0.69-0.55-0.28-0.34
Cash from Financing Activity -3.814.33-0.871.050.00-0.240.090.090.05-1.051.07-0.07
Net Cash Flow -2.130.021.38-1.252.141.54-0.01-0.190.08-1.081.05-0.29
Free Cash Flow 2.07-3.822.09-3.033.06-0.671.040.520.410.480.250.06
CFO/OP % 509.00-368.00233.00-382.00285.00-73.00138.00152.00160.00144.0093.0035.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 25.1546.2316.8254.4313.9939.7732.2447.3843.3896.3596.6560.51
Inventory Days 32.57149.2134.2768.2234.8123.0618.4942.2055.5651.4955.6591.60
Days Payable 19.8331.7814.8736.6773.2234.7660.2578.7043.21108.4991.0778.31
Cash Conversion Cycle 37.89163.6636.2285.99-24.4128.07-9.5210.8855.7239.3561.2373.80
Working Capital Days 43.8230.1721.8742.94-27.4629.83-10.838.0332.2756.6810.2864.38
ROCE % 8.669.9110.778.8612.9014.3210.688.127.164.774.215.98

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 50.04 50.04 50.04 49.96 49.92 49.91 49.85 49.80 49.80 49.42 49.38 49.38
Public 49.96 49.97 49.95 50.04 50.09 50.08 50.14 50.19 50.20 50.58 50.62 50.62
No. of Shareholders 5,146 5,194 5,263 5,320 5,341 5,398 5,412 5,555 5,272 5,351 5,283 5,134

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Other 10 May 2019 โ€” โ€” โ€” E.G.M.

Announcements

5 filings